Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015-2016.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

31 citing papers in PubMed, 86 citations in OpenAlex.

1. Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in adolescents and adults: phase III randomized study.Pediatric research · 2023
   Trial
2. Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers: A randomised, controlled trial.Human vaccines & immunotherapeutics · 2022
   Trial
3. Modeling antibody persistence after MenACYW-TT vaccination and comparative analysis with other quadrivalent meningococcal vaccines.Scientific reports · 2025
   Article
4. Public Health Impact of Potential Infant MenACWY Vaccination Strategies in Spain.Vaccines · 2025
   Article
5. Public health impact and cost-effectiveness of introducing MenACWY vaccination strategies in Germany.BMC public health · 2025
   Article
6. Epidemiology of Meningococcal Disease in Four South American Countries and Rationale of Vaccination in Adolescents from the Region: Position Paper of the Latin American Society of Pediatric Infectious Diseases (SLIPE).Vaccines · 2023
   Article
7. Factors associated with COVID-19 vaccine uptake in adolescents: a national cross-sectional study, August 2021-January 2022, England.BMJ open · 2023
   Observational
8. Trends in laboratory-confirmed bacterial meningitis (2012-2019): national observational study, England.The Lancet regional health. Europe · 2023
   Article
9. Real-world impact and effectiveness of MenACWY-TT.Human vaccines & immunotherapeutics · 2023
   Review
10. Epidemiology, clinical features and outcome of adults with meningococcal meningitis: a 15-year prospective nationwide cohort study.The Lancet regional health. Europe · 2023
    Article
11. Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
12. Evolving strategies for meningococcal vaccination in Europe: Overview and key determinants for current and future considerations.Pathogens and global health · 2022
    Review
13. Meningococcal Disease Outbreaks: A Moving Target and a Case for Routine Preventative Vaccination.Infectious diseases and therapy · 2021
    Review
14. The Epidemiology of Invasive Meningococcal Disease in the Kingdom of Saudi Arabia: A Narrative Review with Updated Analysis.Infectious diseases and therapy · 2021
    Review
15. TIPICO XI: report of the first series and podcast on infectious diseases and vaccines (aTIPICO).Human vaccines & immunotherapeutics · 2021
    Article
16. Risk factors for carriage of meningococcus in third-level students in Ireland: an unsupervised machine learning approach.Human vaccines & immunotherapeutics · 2021
    Article
17. Invasive Meningococcal Disease, 2011-2020, and Impact of the COVID-19 Pandemic, England.Emerging infectious diseases · 2021
    Article
18. Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccines.Human vaccines & immunotherapeutics · 2021
    Review
19. [Journal of preventive medicine and hygiene · 2021
    Article
20. Herd Protection against Meningococcal Disease through Vaccination.Microorganisms · 2020
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

6 authors at 2 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as